Location History:
- Augsburg, DE (1987)
- Tubingen, DE (1992 - 1999)
Company Filing History:
2 out of 1,164 
1 out of 133 
1 out of 2 
Years Active: 1987-1999
Title: **Friedrich Gotz: A Pioneer in Peptide Innovation**
Introduction
Friedrich Gotz, an accomplished inventor based in Tübingen, Germany, has significantly impacted the field of biochemistry with his innovative approaches to peptide synthesis and biosynthetic processes. With a remarkable portfolio of five patents to his name, Gotz continues to push the boundaries of scientific research and application.
Latest Patents
His latest patents include groundbreaking methods such as the "Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD," which outlines a technique for the oxidatively decarboxylating of peptides. This method involves the combination of a peptide with EpiD, focusing on specific amino acid sequences that facilitate this chemical transformation.
Additionally, Gotz has developed a "Biosynthetic process for the preparation of chemical compounds," describing a transformed bacterial host using a plasmid that encodes a polypeptide precursor. This complex is capable of producing polypeptides containing dehydroamino acids and lanthione bridges, including gallidermin. His contributions also include the disclosure of recombinant DNA molecules essential for the biosynthesis of the lantibiotic epidermin.
Career Highlights
Friedrich Gotz made substantial strides in his career while working for leading companies such as Boehringer Mannheim GmbH and Dr. Karl Thomae GmbH. His tenure at these organizations allowed him to translate his innovative ideas into practical applications that benefit the field of biochemistry and beyond.
Collaborations
Throughout his career, Gotz has collaborated with esteemed colleagues, including Thomas Kupke and Gunther Jung. These partnerships have enabled him to combine expertise and knowledge, enhancing the quality and impact of his research in peptide chemistry.
Conclusion
Friedrich Gotz stands as a significant figure in the world of peptide innovation. His patents exemplify his dedication to advancing biochemistry through inventive methodologies. With ongoing research and collaboration, Gotz’s work promises to continue shaping the future of chemical compound synthesis and biosynthetic processes.